2010;55:1067 75. 1007. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eightyear outcomes. J Am Coll Cardiol. 2003;41:1293 304. 1008. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082 9. 1009. Malenka DJ, Leavitt BJ, Hearne MJ, et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circu- lation. 2005;112:I371 I376. 1010. Niles NW, McGrath PD, Malenka D, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or per- cutaneous coronary revascularization: results of a large regional pro- spective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol. 2001;37:1008 15. 1011. Weintraub WS, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multi- vessel coronary artery disease. J Am Coll Cardiol. 1998;31:10 9. 1012. Benzer W, Hofer S, Oldridge NB. Health-related quality of life in patients with coronary artery disease after different treatments for angina in routine clinical practice. Herz. 2003;28:421 8. 1013. Bonaros N, Schachner T, Ohlinger A, et al. Assessment of healthrelated quality of life after coronary revascularization. Heart Surg Forum. 2005;8:E380 E385. 1014. Bucher HC, Hengstler P, Schindler C, et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ. 2000;321:73 7. 1015. Favarato ME, Hueb W, Boden WE, et al. 